Viewing Study NCT07330492


Ignite Creation Date: 2026-03-26 @ 3:15 PM
Ignite Modification Date: 2026-03-31 @ 5:52 AM
Study NCT ID: NCT07330492
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-01-09
First Post: 2025-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Testing a Brief Reassurance Message Before a Musculoskeletal Clinic Visit
Sponsor: University of Texas at Austin
Organization:

Study Overview

Official Title: Randomized Controlled Trial of a Nudge Intervention for Common Musculoskeletal Conditions
Status: NOT_YET_RECRUITING
Status Verified Date: 2026-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this clinical trial is to learn if a brief, reassuring pre-visit message affects patients' expectations and planned follow-up care in adults with common musculoskeletal conditions. The main questions it aims to answer are:

* Does reading a brief reassurance message before a clinic visit change how interested patients are in additional care, such as follow-up visits, tests, injections, or surgery?
* Does the message affect whether patients actually schedule follow-up care after the visit?

Researchers will compare participants who receive the pre-visit reassurance message to those who receive usual care to see if the message changes patients' enthusiasm for care or their follow-up decisions.

Participants will:

1. Read a short, easy-to-understand message about musculoskeletal symptoms and options for care (for those in the intervention group)
2. Complete a brief questionnaire rating their interest in follow-up visits, tests, injections, or surgery
3. Have their scheduled follow-up care recorded after the clinic visit
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: